Silk Road Medical to Report Third Quarter 2020 Financial Results on November 10, 2020

Rhea-AI Summary

Silk Road Medical, Inc. (NASDAQ: SILK) announced it will release its third quarter 2020 financial results after market close on November 10, 2020. A conference call for investors will follow at 1:30 PM PT / 4:30 PM ET. Participants can join by calling (844) 883-3861 for domestic or (574) 990-9820 for international access, using conference ID 3146919. The company focuses on reducing stroke risk through its flagship TransCarotid Artery Revascularization (TCAR) procedure, which effectively treats carotid artery blockages.

Positive

• Company focusing on reducing stroke risk, indicating strong potential demand for its products.
• Upcoming financial results announcement could provide investors with insights into growth and performance.

Negative

• None.

SUNNYVALE, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2020 after market close on Tuesday, November 10, 2020. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 3146919. A live and archived webcast of the event will be available at https://investors.silkroadmed.com/.    

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company’s flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Caroline Paul
Gilmartin Group
investors@silkroadmed.com

FAQ

What is the date for Silk Road Medical's Q3 2020 financial results release?

Silk Road Medical will release its Q3 2020 financial results on November 10, 2020.

What is the significance of the conference call scheduled for November 10, 2020?

The conference call will provide insights into Silk Road Medical's financial performance and strategy following the Q3 2020 results.

What is the main focus of Silk Road Medical?

Silk Road Medical focuses on reducing the risk of stroke through its medical device innovations, particularly the TCAR procedure.

How can I listen to the conference call for Q3 2020 results?

Investors can listen by calling (844) 883-3861 for domestic calls or (574) 990-9820 for international calls, using conference ID 3146919.